Exela Tries To Escape Ruling, Nix Painkiller Patent Again
Exela Pharma Sciences LLC and its subsidiaries asked a Delaware federal judge to reconsider a recent ruling that they infringed Cadence Pharmaceuticals Inc.'s patents by creating a generic version of injectable-painkiller...To view the full article, register now.
Already a subscriber? Click here to view full article